Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Ambient-Stable Biologic Product Formulation

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract seeks the development of advanced stabilization techniques to enable biologic products to maintain full efficacy when stored at ambient temperatures ranging from 20 to 25 degrees Celsius, with a target shelf life of 2 to 5 years. This effort is focused on overcoming the current reliance on cold-chain logistics by creating formulation solutions that preserve structural integrity, biological activity, and safety of sensitive biologics under real-world storage conditions. The work will involve innovative approaches in excipient design, lyophilization, nano-encapsulation, or other emerging technologies that prevent degradation pathways such as aggregation, deamidation, and oxidation without the need for refrigeration. This subcontract is issued by the Agency for Strategic Preparedness and Response within the Department of Health and Human Services under NAICS code 325412, which covers pharmaceutical and biological product manufacturing. The opportunity was posted on July 28, 2026, with a response deadline of August 28, 2026. Performance is expected to take place in the area associated with ZIP code 77416, though no specific city or state is provided. The contract aims to bolster national preparedness by ensuring reliable access to life-saving biologics during emergencies, in resource-limited settings, or in regions with inconsistent infrastructure, reducing dependency on temperature-controlled distribution systems.

General Info

Develop ambient-temperature-stable biologics with 2–5 year shelf life using advanced formulations to eliminate cold-chain reliance.

Agency

Department Of Health And Human Services → Aspr Administration For Strategic Preparedness And ResponseView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

77416, DC, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Aspr Administration For Strategic Preparedness And Response
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → Aspr Administration For Strategic Preparedness And Response
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Development of stabilization techniques to ensure biologic product efficacy at ambient temperatures (20–25°C) with 2–5 year shelf life.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
FLUORESCEIN SODIUM OPHFluorescein Sodium Ophthalmic Strips, USP, are procured as a single unit of 100 individually sealed strips at 1 mg each, packaged in commercial unit containers designed to prevent damage or breakage, with exterior shipping containers ensuring safe and cost-effective delivery to the designated point of supply. All packaging and marking must comply with Medical Marking Standard No. 1, replacing MIL-STD-129, and must include the NSN, manufacturer, CAGE code, date of manufacture, expiration or retest date, and contract or lot number. The product has a non-extendable shelf life of 36 months as a TYPE I (CODE Q) item. Mercury and mercury-containing compounds are strictly prohibited from intentional addition or direct contact with the product, with exceptions limited to specific functional uses in batteries, lighting, instruments, sensors, controls, weapon systems, or NAVSEA-approved chemical reagents; portable fluorescent lamps or instruments containing mercury must be shockproof and include a secondary containment barrier per NAVSEA 5100-003D. Suppliers must submit Safety Data Sheets (SDS) and Hazard Communication Standard (HCS) compliant labels in accordance with 29 C.F.R. 1910.1200, replacing MSDS requirements effective June 1, 2015, and ensure employee training on all updated labeling and documentation standards. The item is regulated by the FDA, and buyers must submit referrals to confirm compliance. Delivery is FOB destination within 20 days with no variance allowed in quantity, and the product must adhere to MIL-STD-2073-1E packaging standards. The contract reference is SPE2DP-26-T-4346, with a response deadline of August 3, 2026, and the point of contact is James McCullough at DLA Troop Support.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 22 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
ZINC OXIDE OINTMENTThe contract specifies the procurement of Zinc Oxide Ointment USP, a topical skin protectant containing 20% zinc oxide, packaged in 1-ounce collapsible tubes weighing 28.35 grams each, with the unit of issue being the tube. The product must comply with FDA regulations and meet stringent technical and quality standards as defined by the DLA Master List of Technical and Quality Requirements, including proper labeling per MEDICAL MARKING STANDARD NO. 1 and packaging consistent with MIL-STD-129 and RP001. The ointment has a non-extendable shelf life of 36 months and must be stored at controlled room temperature not exceeding 30°C (86°F). The item is identified by NSN 6505-00-150-1990 and manufacturer part number NDC67777-0223-11 supplied by DYNAREX CORP. Two delivery line items are specified: 10 tubes for delivery to Richmond, Virginia, and 4 tubes for delivery to Melrose, Massachusetts. Both shipments are required within five days of contract award, delivered FOB destination with zero quantity variance, inspected and accepted at the destination. Packaging must adhere to ASTM D3951 if non-hazardous, but DLA requirements supersede all others. Shipping must occur via traceable methods, excluding parcel post, and all markings must follow government specifications. The original required delivery dates are July 29 and July 30, 2026, with the contract solicitation number SPE2DP-26-T-4335 and point of contact James McCullough.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 22 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
ZOLMITRIPTAN TABLETZolmitriptan tablets, 2.5 mg film-coated, are supplied in blister packs containing six tablets per package, with the unit of issue defined as a package of six units. The product must be stored at controlled room temperature and marked in accordance with the latest edition of the Medical Marking Standard No. 1, adhering to DLA packaging requirements and technical quality standards as outlined in the DLA Master List of Technical and Quality Requirements. The item is classified as a Type I (Code Q) drug with a non-extendable shelf life of 36 months, and all supplies must comply with removal of government identification if not accepted, with potential application of Covered Defense Information protocols. The contract specifies two manufacturer part numbers—NDC71626-0101-06 from Medstone Pharma LLC and NDC60846-0130-30 from Amneal Pharmaceuticals of New York, LLC—both subject to FDA regulation and requiring prior confirmation via EBS referral by the contracting official. The delivery instruction requires FOB destination within 20 days, with no variance allowed in quantity, inspection and acceptance occurring at the delivery point, and packaging must meet MIL-STD-2073-1E standards. The contract, issued under solicitation SPE2DP-26-T-4332, has a posted date of July 28, 2026, and a response deadline of August 3, 2026, with three packages totaling 18 tablets ordered at $3.00 per package. The item is linked to NSN 6505015232352 and classified under NAICS code 325412 for pharmaceutical manufacturing.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 22 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
MOXIFLOXACIN HYDROCHLOMoxifloxacin Hydrochloride Tablets, 400 mg in 30-count bottles, are procured under solicitation SPE2DP-26-T-4348 with a required delivery of 10 bottles within 20 days FOB destination. Each bottle contains 30 tablets, with the unit of issue defined as a bottle, and the total quantity ordered is 10 bottles. The product must comply with strict packaging and labeling requirements as outlined in Medical Marking Standard No. 1, superseding all references to MIL-STD-129, and must be shipped using traceable means, excluding parcel post. The item is classified as a Type I (Code Q) medical product with a non-extendable shelf life of 36 months and must be stored at controlled room temperature while avoiding high humidity. Manufacturer information is specified, with TEVA PHARMACEUTICALS USA, INC. and RISING PHARMA HOLDINGS, INC. listed as suppliers, each with designated NDC numbers. All packaging must meet commercial standards per ASTM D3951 unless the material is hazardous, in which case Federal Standard 313 applies, though DLA Master List of Technical and Quality Requirements override all other standards. The delivery destination is USS GRIDLEY DDG 101, FPO AP 96666, with shipping instructions tied to DLA Procurement Note C19 and RDD 777. The contract includes a zero variance tolerance on quantity, inspection and acceptance occur at destination, and the product is subject to FDA regulation. The solicitation requires buyers to submit referrals via EBS to confirm bidder and manufacturer details, and the contract is governed by DLA’s technical and quality requirements effective at the time of award, with all markings and packaging strictly aligned to current DLA medical marking standards.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 22 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
RINGER'S INJECTION, LACRINGER'S INJECTION, LACTATED, USP, 1000ML in packs of 12 units per case, is being procured under contract SPE2DP-26-T-4338 with a total quantity of 3 cases, each containing 12 units, for delivery to Bogalusa, LA within five days under FOB destination terms. The product must be packaged in sealed unit containers that protect against damage and shipped in commercial exterior containers suitable for safe transport by common carrier at the lowest cost, conforming to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The item, manufactured by B. BROWN MEDICAL INC with NDC 00264-7750-00, has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C) with brief exposure up to 40°C permitted; freezing and excessive heat must be avoided. All packaging and labeling must adhere to the latest version of the Medical Marking Standard No. 1, available through DLA Troop Support, and technical and quality requirements referenced by R or I numbers are governed by the DLA Master List in effect at the solicitation or award date. The contract specifies zero variance in quantity, inspection and acceptance occur at delivery point, and government identification must be removed from non-accepted supplies. The FDA regulates this drug, requiring buyer referral via EBS to the product specialist, including manufacturer and bidder details. The purchase is under the DoD unit of issue system, and procurement falls under NAICS 325412.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 22 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
EMOLLIENT LOTIONThe contract specifies the procurement of 2 bottles of Emollient Lotion, each containing 240 mL (8 FL OZ), packaged in a non-sterile bottle with a dispenser cap. The lotion must be an oil-in-water or water-in-oil emulsion containing a minimum of water, a suitable oil, an emulsifier, and a preservative, with additional compliant ingredients such as stabilizers, thickening agents, emollients, surfactants, humectants, colorants, and fragrances permitted in sufficient quantities. It must maintain a pH between 5.0 and 8.1 and exhibit a viscosity of 10,000 to 20,000 CPS at 25°C when measured with a Brookfield Viscometer Model LVT using Spindle No. 13 at 6 RPM. The product is regulated by the FDA and must be stored at controlled room temperature. Packaging and marking must comply with the latest Medical Marking Standard No. 1 and MIL-STD-129, with commercial packaging adhering to ASTM D3951 unless superseded by stricter DLA requirements. The unit of issue is a bottle (BT), and delivery is required FOB destination within 20 days of contract award to a military installation at Fort Bliss, Texas. No quantity variance is permitted, and inspection and acceptance occur at the destination. Traceable shipping methods are mandatory, and parcel post is prohibited. The contract reference number is SPE2DP-26-T-4329, with a required delivery date of July 29, 2026, and the product is identified by NSN 6508-01-019-7181. The supplier must meet all technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 22 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DEXTROSE INJECTIONDextrose Injection 5% USP is a sterile, nonpyrogenic intravenous solution supplied in 1000 mL single-dose plastic bags, with each bag containing 50 grams of anhydrous dextrose USP dissolved in water for injection USP. The product is latex-free and intended solely for intravenous administration, packaged in units of 12 bags per package. It is classified as a Type I (Code P) item with a non-extendable shelf life of 30 months and must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), protected from freezing and excessive heat. The item is subject to the latest Medical Marking Standard No. 1 for labeling and packaging, and defense information may apply under RD003. Packaging and delivery must comply with MIL-STD-2073-1E. The solicitation SPE2DP-26-T-4336 calls for two packages (24 bags total) to be delivered within five days FOB destination, with no variance allowed in quantity. Inspection and acceptance occur at the delivery point, and the contract is managed by the Department of Defense under the Medical Supply Chain PHARM FSA. The item is identified by NSN 6505-01-330-6252 and is procured under a fixed unit price; only suppliers meeting the DLA Master List of Technical and Quality Requirements referenced in RA001 are eligible. The contract is part of a federal procurement with NAICS code 325412, and the primary point of contact is James Foggie at DLA. Manufacturers listed include ICU Medical, Inc. and B. Braun Medical Inc., each with approved NDCs.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 22 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
SODIUM PERBORATESodium peroxide in powder form, packaged in 100-gram bottles, is being procured under solicitation SPE2DP-26-T-4343 with a strict requirement of one unit of issue per bottle and a delivery deadline of five days after award. The item has a non-extendable shelf life of 36 months and must be stored away from high humidity and temperatures exceeding 32 degrees Celsius, as well as kept separate from flammable materials due to its chemical nature. Packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and adhere to DLA packaging requirements, with hazardous material handling governed by TQ requirement IP025 if classified under FED-STD-313, otherwise meeting ASTM D3951 commercial packaging standards, though DLA’s technical and quality requirements take precedence. The item is regulated by the FDA, requiring a referral through EBS to confirm specifications, and must be shipped via traceable freight methods—parcel post is prohibited. Delivery is FOB destination to PCU JOHN F KENNEDY CVN-79 in Suffolk, Virginia, with no variance allowed in quantity. The contract references the DLA Master List of Technical and Quality Requirements for compliance, and the supplier must clearly identify the source and part number, with approved vendors including Sultan Chemists Inc., Henry Schein Inc., and Patterson Dental Supply, Inc. The required delivery date is July 30, 2026, and the solicitation response deadline is August 3, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 22 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
CHLORINE TEST REAGEThe contract specifies the procurement of Chlorine Test Reagent, a DPD total chlorine reagent packaged in 100 powder pillows, each designed for a 10 mL sample size, with the unit of issue being one package containing 100 units. The item is identified by NSN 6550-01-460-7597 and requires a shelf life of 60 months, non-extendable, with no more than eight months elapsed from the date of manufacture to the date of delivery to the government. Packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and all labels must clearly indicate the date of manufacture, expiration or retest date, and the contract or lot number, in accordance with the latest revision of MMS1C. The reagent must be shipped in sealed, commercial-grade containers capable of protecting against damage and must be packed in exterior shipping containers suitable for safe delivery at the lowest possible rate to the specified point of delivery, FPO ZIP 09578. Technical and quality requirements referenced by R or I numbers are governed by the DLA Master List, and applicable defense information controls are in effect. Supply packaging adheres to DLA packaging standards, and government identification must be removed from non-accepted supplies. The solicitation number is SPE2DS-26-T-79S, issued on July 28, 2026, with a response deadline of August 3, 2026, under a federal procurement managed by the Department of Defense’s Medical Supply Chain MD Surg FSF office, and delivery is required within 20 days after award.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 22 hours ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Health And Human Services → Aspr Administration For Strategic Preparedness And Response

Same awarding agency

NAICS: 541711
New
Federal
Clinical Trial Design and Efficacy Data GenerationThe contract calls for the design and execution of clinical trials aimed at evaluating the safety, wound closure, infection control, and functional regeneration outcomes of medical interventions in patients with burn and trauma injuries. The work requires rigorous scientific methodology to generate robust efficacy data that supports regulatory and clinical adoption, with a focus on measurable endpoints related to tissue recovery and patient outcomes. The trials must be conducted in accordance with established clinical standards and are intended to provide evidence of therapeutic effectiveness under real-world conditions. This is a subcontract under the Aspr Administration for Strategic Preparedness and Response, part of the Department of Health and Human Services, with a solicitation posted on July 28, 2026, and a response deadline of August 28, 2026. The work is classified under NAICS code 541711, indicating research and development in the life sciences. The performance location is designated with a zip code of 77416, though no specific city or state is provided, and no point of contact details are listed. The contract does not include a set-aside designation, and all eligible entities may respond, with emphasis placed on technical capability, trial design expertise, and experience in trauma and burn clinical research.
Research and Development in Biotechnology

POSTED

1 day ago

DEADLINE

in about 1 month
View Details
NAICS: 484121
New
Federal
Nationwide and International Medical Logistics & DistributionThe contract enables the rapid deployment and distribution of dermal substitutes across the United States and internationally, relying on resilient supply chains that operate under ambient conditions without the need for refrigeration or specialized storage. This effort supports the strategic medical preparedness goals of the Department of Health and Human Services’ Administration for Strategic Preparedness and Response, ensuring timely access to critical wound care solutions during emergencies or large-scale health events. The logistics network must be scalable, responsive, and capable of maintaining product integrity through diverse environmental and geographic conditions. Subcontractors are expected to manage end-to-end distribution channels that are efficient, secure, and compliant with federal medical logistics standards. The opportunity is open for bidding until August 28, 2026, with performance centered on a primary location identified by the zip code 77416. The NAICS code 484121 indicates that the work falls under general freight trucking, suggesting a heavy reliance on ground transportation infrastructure, though global reach implies coordinated international shipping protocols. There is no set-aside designation, making it accessible to all qualified vendors regardless of business size or ownership structure.
General Freight Trucking, Long-Distance, Truckload

POSTED

1 day ago

DEADLINE

in about 1 month
View Details
NAICS: 541611
New
Federal
Regulatory Strategy and FDA Submission SupportThe contract seeks comprehensive support for regulatory documentation and submissions to secure FDA approval or clearance for a dermal substitute, covering all critical pathways including Investigational Device Exemption IDE, 510(k) premarket notification, and Premarket Approval PMA. The work involves developing strategic regulatory plans, preparing technical and clinical documentation, coordinating with FDA reviewers, and ensuring compliance with all applicable federal requirements throughout the submission lifecycle. The contractor will be responsible for delivering timely, accurate, and scientifically robust submissions that align with current regulatory expectations and facilitate timely decision-making by the agency. This subcontract is issued under the authority of the Assistant Secretary for Preparedness and Response, part of the Department of Health and Human Services, with a North American Industry Classification System code of 541611 for management, scientific, and technical consulting services. The opportunity was posted on July 28, 2026, and responses are due by August 28, 2026. Performance is expected to be conducted from a location with a zip code of 77416, though no specific city or state is designated. The contract does not specify any set-aside status, and no point of contact information is provided publicly, with the full details accessible via the SAM.gov link.
Administrative Management and General Management Consulting Services

POSTED

1 day ago

DEADLINE

in about 1 month
View Details
NAICS: 325411
New
Federal
Surge-Capable Domestic BiomanufacturingThe contract seeks to establish large-scale domestic manufacturing of dermal substitutes in the United States with built-in surge capacity to support mass casualty and emergency response scenarios. The effort is focused on creating a resilient, onshore production capability capable of rapidly scaling output during public health emergencies, ensuring timely availability of critical wound care products when demand spikes. This initiative is aligned with national preparedness goals and underscores a strategic push to reduce reliance on overseas supply chains for life-saving medical materials. The award is structured as a subcontract under the Administration for Strategic Preparedness and Response within the Department of Health and Human Services, with a North American Industry Classification System code of 325411 for pharmaceutical and medicine manufacturing. The solicitation was posted on July 28, 2026, and responses are due by August 28, 2026. Although the place of performance is listed with a zip code of 77416, no specific city or state is provided, and no point of contact details are included. The contract does not specify a set-aside status, indicating it is open to all qualified entities regardless of size or ownership. The focus remains on achieving domestic production capacity that can maintain steady output and immediately ramp up during crises.
Medicinal and Botanical Manufacturing

POSTED

1 day ago

DEADLINE

in about 1 month
View Details
NAICS: 339113
New
Federal
Advanced Dermal Regeneration Substitutes for Treatment of Severe Burns and Complex Traumatic InjuriesThe Biomedical Advanced Research and Development Authority (BARDA) is seeking information on advanced dermal regeneration technologies capable of addressing large-area skin loss resulting from thermal burns or traumatic injuries in mass casualty scenarios. The solicitation, titled Advanced Dermal Regeneration Substitutes for Treatment of Severe Burns and Complex Traumatic Injuries and identified by BARDA-CBRN-07282026, aims to evaluate commercially available or near-commercial technologies that support temporizing wound healing, accelerate wound closure, control infection, and enable functional tissue regeneration. This is not a contract award announcement but a sources-sought notice designed to inform future acquisition strategies by assessing the current landscape of medical countermeasure innovations. Respondents are encouraged to submit documentation demonstrating the readiness, performance, and scalability of their technologies to meet operational needs in high-volume, high-acuity environments. The opportunity is open for responses until August 28, 2026, at 8:00 PM Eastern Time, with all submissions directed to the point of contact, Yifan Yang, at yifan.yang@hhs.gov. The procurement falls under NAICS code 339113, which pertains to medical appliance and equipment manufacturing, and is administered by the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services. There is no small business set-aside, and the office is based in Washington, D.C. The place of performance is also located in the District of Columbia, indicating that evaluation and potential oversight will be centralized at the federal level. Interested parties can access further details through the provided SAM.gov link.
Surgical Appliance and Supplies Manufacturing

POSTED

1 day ago

DEADLINE

in about 1 month
View Details